Back to search

Biocortex Ltd

13287534

active
Private Limited Company
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Current liabilities exceed current assets (-10)

Details

167-169 GREAT PORTLAND STREET, LONDON, W1W 5PF
Incorporated 23/03/2021

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Mr Muhannad Al-Omari

director · Since 23/03/2021

CHIEF TECHNOLOGY OFFICER

JORDANIAN · ENGLAND · Age 38

Also on 2 other boards

Dr Nikhil Sharma

director · Since 23/03/2021

CHIEF EXECUTIVE OFFICER

BRITISH · ENGLAND · Age 52

Also on 2 other boards

Mr Hussein Kanji

director · Since 31/10/2022

VENTURE CAPITALIST

AMERICAN · ENGLAND · Age 49

Also on 10 other boards

Mr Edward Gerrit Roelof Kliphuis

director · Since 31/10/2022

PARTNER AT VC FIRM

DUTCH · SPAIN · Age 41

Also on 2 other boards

Persons with Significant Control

Biocortex Inc.

75–100% shares
75–100% votes

1209, 1209 Orange Street, County Of New Castle, 19801

Reg: 7348049 · The Secretary Of State Of The State Of Delaware Division Of Corporations · Private Limited Company (Delaware Corporation)

Notified 23/05/2023

Former PSCs

Dr Nikhil Sharma

Ceased 23/05/2023

Mr Muhannad Al-Omari

Ceased 23/05/2023

CompanyRankvs 14940+ SIC 72110 peers
54

Financial strength57th percentile among SIC peers · 14/25
Employees94th percentile among SIC peers · 14/15
LiquidityCurrent ratio 0.7× · 6/20
Longevity5 years trading (max 15) · 5/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Labgenius Limited
89
9Nuclera Ltd
88
10Aparito Limited
87
1494Biocortex Ltd
50
How is this score calculated?
Financial strength14/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity6/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity5/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/03/2025

Net Worth

£2k

Balance sheet strength

Cash

£401k

Cash in the bank

Net Current Assets

-£491k

Working capital

Current Assets

£1.1M

Current Liabilities

£1.6M

Fixed Assets

£134k

Debtors

£738k

13avg. employees

Balance Sheet

Intangible assets£25k
Assets less current liabilities-£357k
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20250.70+£0
202412.96-£3.6M
202328.25+£3.6M
20220.93—

Derived from filed accounts. Not audited figures.